Patient info Open main menu

L01ED01 crizotinib

ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)

This site has the patient leaflet or the SPC of 5 medicines in this group.

Active substance: Crizotinib – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L01 Antineoplastic agents 1,025 medicines
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
        1. L01ED Anaplastic lymphoma kinase (ALK) inhibitors 14 medicines
          1. L01ED01 crizotinib 5 medicines

Medicines

MedicineLegal category
Xalkori 150 mg granules in capsules for Opening SPC Prescription only (POM)
Xalkori 20 mg granules in capsules for Opening SPC Prescription only (POM)
Xalkori 200 mg hard capsules SPC Prescription only (POM)
Xalkori 250 mg hard capsules SPC Prescription only (POM)
Xalkori 50 mg granules in capsules for Opening Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L01ED01

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.